Your browser doesn't support javascript.
loading
A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.
Ostrowitzki, Susanne; Lasser, Robert A; Dorflinger, Ernest; Scheltens, Philip; Barkhof, Frederik; Nikolcheva, Tania; Ashford, Elizabeth; Retout, Sylvie; Hofmann, Carsten; Delmar, Paul; Klein, Gregory; Andjelkovic, Mirjana; Dubois, Bruno; Boada, Mercè; Blennow, Kaj; Santarelli, Luca; Fontoura, Paulo.
Afiliação
  • Ostrowitzki S; Product Development, Neuroscience, Genentech Inc., South San Francisco, CA, USA.
  • Lasser RA; MedDay Pharmaceuticals, Boston, MA, USA.
  • Dorflinger E; Formerly Roche Translational & Clinical Research Center, New York, NY, USA.
  • Scheltens P; VU University Medical Center, Amsterdam, The Netherlands.
  • Barkhof F; VU University Medical Center, Amsterdam, The Netherlands.
  • Nikolcheva T; Institute of Neurology, UCL, London, UK.
  • Ashford E; Roche Pharma Research and Early Development, NORD, Basel, Switzerland.
  • Retout S; Roche Pharma Research and Early Development, NORD, Basel, Switzerland.
  • Hofmann C; Roche Products Limited, Welwyn Garden City, UK.
  • Delmar P; Roche Pharma Research and Early Development, Clinical Pharmacology, Roche Innovation Center, Basel, Switzerland.
  • Klein G; Roche Pharma Research and Early Development, Clinical Pharmacology, Roche Innovation Center, Basel, Switzerland.
  • Andjelkovic M; Clinical Pharmacology and Bioanalytical R&D, Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
  • Dubois B; Roche Pharma Research and Early Development, NORD, Basel, Switzerland.
  • Boada M; Roche Pharma Research and Early Development, Clinical Pharmacology, Roche Innovation Center, Basel, Switzerland.
  • Blennow K; Alzheimer Institute and ICM, UMR-S975, Salpêtrière University Hospital, AP-HP, Pierre and Marie Curie University, Paris, France.
  • Santarelli L; Research Center and Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain.
  • Fontoura P; Research Center and Memory Clinic of Fundació ACE, Institut Català de Neurociències Aplicades, Barcelona, Spain.
Alzheimers Res Ther ; 9(1): 95, 2017 Dec 08.
Article em En | MEDLINE | ID: mdl-29221491
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Sintomas Prodrômicos / Fatores Imunológicos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Sintomas Prodrômicos / Fatores Imunológicos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Observational_studies Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article